These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 36045442

  • 1. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
    Liu T, Zhang X, Long L, Zhou L, Chen J, Li M, Gao Y, Zhou X, Han X, Ji L.
    BMC Endocr Disord; 2022 Aug 31; 22(1):218. PubMed ID: 36045442
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L, Trimboli P, Keller F, Imperiali M, Piccardo A, Giovanella L.
    Clin Endocrinol (Oxf); 2020 Feb 31; 92(2):169-178. PubMed ID: 31742747
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease.
    Tozzoli R, D'Aurizio F, Villalta D, Giovanella L.
    Clin Chem Lab Med; 2017 Jan 01; 55(1):58-64. PubMed ID: 27331310
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease.
    Xu S, Shao W, Wu Q, Zhu J, Pan B, Wang B, Guo W.
    J Clin Lab Anal; 2023 Apr 01; 37(8):e24890. PubMed ID: 37161617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
    Liu K, Fu Y, Li T, Liu S, Chen D, Zhao C, Shi Y, Cai Y, Yang T, Zheng X.
    Clin Biochem; 2021 Nov 01; 97():34-40. PubMed ID: 34331946
    [Abstract] [Full Text] [Related]

  • 7. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
    Smit MA, van Kinschot CMJ, van der Linden J, van Noord C, Kos S.
    Neth J Med; 2020 Mar 01; 78(2):55-63. PubMed ID: 32332174
    [Abstract] [Full Text] [Related]

  • 8. Analytical and clinical performance of newly developed immunoassay for detecting thyroid-stimulating immunoglobulin, the Immulite TSI assay.
    Kim JJ, Jeong SH, Kim B, Kim D, Jeong SH.
    Scand J Clin Lab Invest; 2019 Oct 01; 79(6):443-448. PubMed ID: 31453725
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stimulating thyrotropin receptor antibodies in early pregnancy.
    Uldall-Torp NM, Andersen L, Kim HJ, Bruun NH, Karmisholt J, Andersen S, Andersen SL.
    Clin Chem Lab Med; 2024 Oct 28; 62(11):2256-2264. PubMed ID: 38634229
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves' disease.
    Tong M, Ding J, Huang B, Chen J, Wei X, Li Z, Shu J, Hu Z, Jiang X, Sheng H.
    Clin Chim Acta; 2021 Oct 28; 521():34-39. PubMed ID: 34144042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analytical performance evaluation of thyroid-stimulating hormone receptor antibody (TRAb) immunoassays.
    Higgins V, Patel K, Kulasingam V, Beriault DR, Rutledge AC, Selvaratnam R.
    Clin Biochem; 2020 Dec 28; 86():56-60. PubMed ID: 32858059
    [Abstract] [Full Text] [Related]

  • 15. Utility of TSH Receptor Antibodies in the Differential Diagnosis of Hyperthyroidism in Clinical Practice.
    John M, Jagesh R, Unnikrishnan H, Jalaja MMN, Oommen T, Gopinath D.
    Indian J Endocrinol Metab; 2022 Dec 28; 26(1):32-37. PubMed ID: 35662753
    [Abstract] [Full Text] [Related]

  • 16. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
    Khamisi S, Lundqvist M, Engström BE, Larsson A, Karlsson FA, Ljunggren Ö.
    Exp Clin Endocrinol Diabetes; 2023 Apr 28; 131(4):236-241. PubMed ID: 36706788
    [Abstract] [Full Text] [Related]

  • 17. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ.
    J Clin Endocrinol Metab; 2010 May 28; 95(5):2123-31. PubMed ID: 20237164
    [Abstract] [Full Text] [Related]

  • 18. Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves' disease.
    Autilio C, Morelli R, Locantore P, Pontecorvi A, Zuppi C, Carrozza C.
    Ann Clin Biochem; 2018 Jan 28; 55(1):172-177. PubMed ID: 28388869
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Stan MN, Algeciras-Schimnich A, Murthy V, Thapa P, Araki N.
    Thyroid; 2022 Feb 28; 32(2):170-176. PubMed ID: 34714163
    [Abstract] [Full Text] [Related]

  • 20. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
    Zuhur SS, Bilen O, Aggul H, Topcu B, Celikkol A, Elbuken G.
    Endokrynol Pol; 2021 Feb 28; 72(1):14-21. PubMed ID: 32944926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.